Sang-A Kim

14PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRegenerative medicine (incl. stem cells)Immunogenetics (incl. genetic immunology)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 07, 2026
Comparison of Thiotepa, Busulfan, and Cyclophosphamide Versus Busulfan and Thiotepa Conditioning Regimens in Autologous Stem Cell Transplantation for Primary CNS Lymphoma: A Multicenter Retrospective Analysis.

|May 07, 2026
Clinicopathological spectrum of CD10, BCL6, MUM1 triple-positive diffuse large B-cell lymphoma and large B-cell lymphoma with IRF4 rearrangement.

|Apr 13, 2026
Comparative Outcomes of Consolidation Strategies After R-MVP Induction in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.

Sang-A Kim, Jung Sun Kim, Ji Yun Lee

|Oct 22, 2024
MG4101, an allogeneic natural killer cell, in patients with relapsed or refractory acute myeloid leukemia: a pilot study.

Sang-A Kim, Miyoung Jung, Hyojin Kim

|Oct 10, 2024
Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome.

Dong Hyun Kim, Seokhyeon Kim, Seonyang Park

|Sep 24, 2024
Direct Oral Anticoagulants in Antiphospholipid Syndrome-Associated Venous Thromboembolism: Real World Evidence.

Hun-Gyu Hwang, Ju Hyun Lee, Sang-A Kim

Pageof 3

Frequent Collaborators

8 joint publications

Soo-Mee Bang

5 joint publications

Jeong-Ok Lee

4 joint publications

Junshik Hong

4 joint publications

Ji Yun Lee